Item |
Description |
FORTRAN |
Columns |
Details |
Abbreviation |
0 |
Trial/stratum identifying code |
I6 |
1 - 6 |
|
Trial |
1 |
Patient identifier (or sequence number) |
A12 |
8 - 19 |
|
Patient |
2 |
Randomisation date |
I6 |
21 - 26 |
DDMMYY |
Rand. Date |
3 |
Treatment group allocated (as on master
list) |
I1 |
28 |
|
Trt. Grp |
4 |
Randomisation age |
I2 |
30 - 31 |
years |
Age |
5 |
Menopausal status on entry |
I1 |
33 |
Value |
Description |
Abbreviation |
1 |
Pre-menopausal |
Pre |
2 |
Peri-menopausal |
Peri |
3 |
Post-menopausal |
Post |
4 |
Artificial |
Arti |
|
Meno |
6 |
Surgery: first mastectomy |
I2 |
35 - 36 |
Value |
Description |
Abbreviation |
1 |
Radical |
Rdcl |
2 |
Total |
Totl |
3 |
Simple without clearance |
SimN |
4 |
Partial with clearance |
ParY |
5 |
Partial without clearance |
ParN |
6 |
Lumpectomy with clearance |
LumY |
7 |
Lumpectomy without clearance |
LumN |
8 |
Partial, clearance unknown |
Par? |
9 |
Lumpectomy, clearance unknown |
Lum? |
10 |
Subcutaneous |
Subc |
11 |
Simple with clearance |
SimY |
12 |
Other |
Othr |
13 |
None |
None |
|
Surg |
7 |
Axillary status on entry |
I2 |
37 - 38 |
Value |
Description |
Abbreviation |
1 |
N0 (clearance) |
pN0 |
2 |
N1-3 (clearance) |
pN1-3 |
3 |
N4+ (clearance) |
pN4+ |
4 |
N- (sample only) |
sN- |
5 |
N+ (sample only) |
sN+ |
6 |
N- (clinical) |
cN- |
7 |
N+ (clinical) |
cN+ |
8 |
N- (method unknown) |
?N- |
9 |
N+ (method unknown) |
?N+ |
10 |
N+ (clearance) |
pN+ |
11 |
Benign lesion |
Benign |
12 |
N- (clinical) N0 (clearance) |
cN-pN0 |
13 |
N- (clinical) N+ (clearance) |
cN-pN+ |
14 |
N+ (clinical) N0 (clearance) |
cN+pN0 |
15 |
N+ (clinical) N+ (clearance) |
cN+pN+ |
16 |
Not breast cancer |
Not BC |
|
Axilla |
8 |
Oestrogen receptor measurement (fmol/mg
protein) |
I4 |
40 - 43 |
Value |
Description |
Abbreviation |
fmol/mg protein |
|
|
-1 |
Negative |
ERpoor |
-2 |
Marginal |
ERpoor |
-3 |
Positive |
ER+ |
-4 |
< 10 fmol/mg protein |
ERpoor |
-5 |
10 - 19 fmol/mg protein |
ER+ |
-6 |
20 - 29 fmol/mg protein |
ER+ |
-7 |
30 - 49 fmol/mg protein |
ER+ |
-8 |
50 - 99 fmol/mg protein |
ER+ |
-9 |
100+ fmol/mg protein |
ER++ |
-10 |
10 - 29 fmol/mg protein |
ER+ |
-11 |
30 - 100 fmol/mg protein |
ER+ |
-12 |
10 - 99 fmol/mg protein |
ER+ |
-13 |
0 fmol/mg protein |
ER0 |
-14 |
10 - 49 fmol/mg protein |
ER+ |
|
Est. Rec., E.R. |
9 |
Progesterone receptor measurement |
I4 |
45 - 48 |
Value |
Description |
Abbreviation |
fmol/mg protein |
|
|
-1 |
Negative |
PRpoor |
-2 |
Marginal |
PRpoor |
-3 |
Positive |
PR+ |
-4 |
< 10 fmol/mg protein |
PRpoor |
-5 |
10 - 19 fmol/mg protein |
PR+ |
-6 |
20 - 29 fmol/mg protein |
PR+ |
-7 |
30 - 49 fmol/mg protein |
PR+ |
-8 |
50 - 99 fmol/mg protein |
PR+ |
-9 |
100+ fmol/mg protein |
PR++ |
-10 |
10 - 29 fmol/mg protein |
PR+ |
-11 |
30 - 100 fmol/mg protein |
PR+ |
-12 |
10 - 99 fmol/mg protein |
PR+ |
-13 |
0 fmol/mg protein |
PR0 |
-14 |
10 - 49 fmol/mg protein |
PR+ |
|
Prg.Rec., P.R. |
10 |
Site of second malignancy |
I4 |
50 - 53 |
Value |
Description |
Abbreviation |
ICD9 |
|
|
140x |
Lip |
Lip |
141x |
Tongue |
Tongue |
142x |
Salivary glands |
Salivary |
143x |
Gingival |
Gingival |
144x |
Mouth floor |
MouFloor, OraF |
145x |
Oral (general) |
Oral |
146x |
Oropharyngeal |
Opharynx |
147x |
Nasopharyngeal |
Npharynx |
148x |
Hypopharyngeal |
Hpharynx, Hpha |
149x |
Oral / throat (general) |
OralThro, Oral |
150x |
Oesophageal |
Oesophag, Oeso |
151x |
Gastric |
Gastric, Gast |
152x |
Small intestine / duodenal |
SmallInt, SBow |
153x |
Colon / colorectal (general) |
Colon, CoRe |
154x |
Rectal |
Rectal, Rect |
155x |
Hepatic |
Hepatic, Hepa |
156x |
Gall bladder / ext. biliary |
Gbladder, Gbla |
157x |
Pancreatic |
Pancreas, Panc |
158x |
Peritoneal / retroperitoneal |
Periton. |
159x |
Digestive / peritoneal (general) |
DigePeri |
160x |
Nasal / middle ear |
E.N.T. |
161x |
Laryngeal |
Larynx, Lary |
162x |
Tracheal / lung / bronchial |
LungBron, Lung |
163x |
Pleural |
Pleura |
164x |
Thymus / heart / mediastinum |
Mediast. |
165x |
Respiratory / thoracic (general) |
RespThor, ReDi |
170x |
Bone |
Bone |
171x |
Soft tissue |
SoftTiss, Soft |
172x |
Melanoma |
Melanoma, Mela |
173x |
Skin (general) |
Skin |
174x |
Contralateral breast cancer |
ContraBC, Cont |
179x |
Uterine (general) |
Uterine |
180x |
Cervical |
Cervical, Cerv |
182x |
Endometrial / corpus uteri |
Endomet., Endo |
183x |
Ovarian |
Ovarian, Ovar |
184x |
Genital tract (general) |
GenitalT, GenT |
188x |
Bladder |
Bladder, Blad |
189x |
Renal / urinary system (general) |
Urinary, Urol |
190x |
Ocular |
Ocular, Eye |
191x |
Cerebral |
Cerebral, Brai |
192x |
C.N.S. (general) |
C.N.S. |
193x |
Thyroid |
Thyroid, Thyr |
194x |
Endocrine glands (general) |
Endocrin |
195x |
Ill-defined site |
Ill-defd |
196x |
Lymph Nodes |
LymphNod |
197x |
Respiratory / digestive systems |
RespDige |
199x |
Not stated |
?/Unk. |
1999 |
Unknown site |
Site?/Unk. |
200x |
Lymphosarcoma / reticulosarcoma |
L/RSarc |
201x |
Hodgkin's disease |
HodgkinD, Hodg |
202x |
Non-Hodgkin's lymphoma / histiocyt. |
N.H.L. |
204x |
Lymphoid leukaemia |
LympLeuk |
205x |
Myeloid leukaemia |
MyelLeuk |
207x |
Other leukaemia |
Leukaem., Leuk |
208x |
Leukaemia (general) |
Leukaem., Leuk |
210x |
Oral, benign |
BenOral |
211x |
Digestive, benign |
BenDiges |
212x |
Respiratory, benign |
BenRespi |
225x |
Cerebral, benign |
BenBrain |
226x |
Thyroid, benign |
BenThyr |
237x |
Endocrine / nervous, uncertain |
EndNerUn, ENU |
238x |
Uncertain |
Uncert |
273x |
Plasma protein disorder |
PlasProt |
284x |
Aplastic anaemia |
Anaemia |
289x |
Other blood disease |
BloodDis |
|
2nd Malig. |
11 |
Date of second malignancy |
I6 |
55 - 60 |
DDMMYY |
2nd Mal. Date |
12 |
Distant/unknown recurrence |
I1 |
62 |
Value |
Description |
Abbreviation |
1 |
No |
No |
2 |
Distant |
Dist |
3 |
Unknown site |
Unk. |
|
Dist. Rec |
13 |
Date of first distant/unk. recurrence |
I6 |
64 - 69 |
DDMMYY |
D-Rec. Date |
14 |
Prior local recurrence |
I1 |
71 |
Value |
Description |
Abbreviation |
1 |
No |
No |
2 |
Yes |
Yes |
3 |
Ipsilateral |
Ipsi |
4 |
Other locoregional |
Othr |
|
Local Rec |
15 |
Date of prior local recurrence |
I6 |
73 - 78 |
DDMMYY |
L-Rec. Date |
16 |
State when last traced |
I1 |
80 |
Value |
Description |
Abbreviation |
1 |
Alive |
Alive |
2 |
Dead |
Dead |
3 |
Lost |
Lost |
4 |
Utterly lost |
Lost+ |
5 |
Alive, ineligible for protocol |
A/in. |
6 |
Dead, ineligible for protocol |
D/in. |
9 |
Lost, presumed dead |
LostD |
10 |
Lost and ineligible |
L/in. |
11 |
Utterly lost and ineligible |
L+/in. |
|
State |
17 |
Date died or last traced |
I6 |
82 - 87 |
DDMMYY |
L.F.U. |
18 |
ICD revision (extra category) |
I1 |
89 |
|
ICDRev |
19 |
Cause of death (ICD) |
I4 |
90 - 93 |
ICD |
D.ICD |
20 |
Cause of death (extra category) |
I2 |
95 - 96 |
Value |
Description |
Abbreviation |
1 |
Iatrogenic |
Iatro |
2 |
Pneumonia |
Pneum |
3 |
Lymphatic and haematopoietic |
Leuk |
4 |
Other second neoplasm |
Neop2 |
5 |
Heart |
Heart |
6 |
Thrombotic or embolic |
ThEmb |
7 |
Cerebrovascular |
Cvasc |
8 |
Extraneous cause |
Extra |
9 |
Not 1 - 8, 13 - 16 and not breast cancer |
NotBC |
10 |
Unspecified non-breast-cancer cause |
NotBC |
11 |
Breast cancer or its metastases |
BCMet |
12 |
Unascertainable cause |
Unkn. |
13 |
Respiratory |
Respi |
14 |
Hepatic |
Hepat |
15 |
Non-pneumonia infective |
Infec |
16 |
Other vascular |
OVasc |
|
Death |
21 |
Name (if given) and comments |
A |
98 - end |
|
Name |